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ABSTRACT
Astrategyispresentedtoselect,poolandspothuman
BAC clones on an array in such a way that each spot
contains five well performing BAC clones, covering
one chromosome arm. A mini-array of 240 spots was
prepared representing all human chromosome arms
ina5-foldaswellassomecontrols,andusedforcom-
parative genomic hybridization (CGH) of 10 cell lines
withaneusomiesfrequentlyfoundinclinicalcytogen-
etics and oncology. Spot-to-spot variation within five
replicates was below 6% and all expected abnormal-
ities were detected 100% correctly. Sensitivity was
such that replacing one BAC clone in a given spot
of five by a BAC clone from another chromosome,
thus resulting in a change in ratio of 20%, was repro-
ducibly detected. Incubation time of the mini-array
was varied and the fluorescently labelled target
DNA was diluted. Typically, aneusomies could be
detectedusing30ngofnon-amplifiedrandomprimed
labelled DNA amounts in a 4 h hybridization reaction.
Potentialapplicationofthesemini-arraysforgenomic
profiling of disseminated tumour cells or of blasto-
meres for preimplantation genetic diagnosis, using
specially designed DNA amplification methods, are
discussed.
INTRODUCTION
Detection of gene ampliﬁcations and deletions by comparative
genomic hybridization (CGH) is typically performed using
arrays consisting of spotted BAC clones that adequately
cover the genome of interest. In the human situation arrays
of 3.5 k BAC elements are mostly used (1). Recently, arrays
with ten times more BAC elements (35 k) have been success-
fully applied to detect aberrations at higher resolution (2).
Since spotted arrays are relatively large (several cm
2), a relat-
ively high amount of ﬂuorescently labelled target DNA is
required to overcome diffusion barriers and achieve equilib-
rium conditions; prerequisites for a successful array-CGH
experiment.
Consequently, hybridization times are in practice at least
24horlonger,andmoreimportantenoughassaymaterialmust
be available to isolate sufﬁcient amounts of DNA. In many
caseshowever,the use ofDNAampliﬁcation methods isindic-
ated to generate sufﬁcient copies of ﬂuorescently labelled
target DNA (typically 1–4 mg). Whereas methods such as
DOP and ligation-mediated PCR have been ﬁne-tuned such
that even single cells can be assayed by conventional CGH on
metaphase chromosomes (3,4), conditions for array-CGH are
different. So far array-CGH of <100 cells has been very cum-
bersome, despite the use of a variety of successful DNA amp-
liﬁcation strategies. One reason for this is the variation of the
ampliﬁcation process that leads to increasing differences in
DNA representation with number of ampliﬁcation cycles
becomes apparent when the readout is performed at higher
genomic resolution i.e. using BAC arrays with at least 1 MB
resolution. In other words, presuming that the quality of the
starting material is optimal, the variation of the mean signal
ratio of all targets (spots) increases with increasing number of
ampliﬁcation steps and increasing array complexity, i.e. the
number of DNA sequence elements spotted on the array.
Although abnormalities can be detected in even relatively
noisy data at the cost of the actual resolution by applying
dedicated software (5,6), at a certain point this becomes
unreliable and unsuccessful.
We hypothesized that the reverse is also true: if the array
complexity is reduced by decreasing the number of BAC
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doi:10.1093/nar/gni161elements (spots) on the chip replacing them with elements of
higher complexity (pools of ﬁve BAC per spot), more amp-
liﬁcation steps are tolerated and the variation in the mean ratio
over the whole genome decreases. Reduction of complexity
can be accomplished in practice by selecting and pooling a
deﬁned number of BACs from the 3.5 k sets that have been
produced for instance by the UCSF Cancer Center (1) or the
Wellcome Trust Sanger Institute (7). The pooled BACs that
together cover a deﬁned region in the genome are then spotted.
The selection strategy is based on the following principles: (i)
only BACs are selected that so far behaved ﬂawless on the
basis of own experience or characteristics listed in the existing
databases; (ii) the number of BACs selected for a particular
region may be tuned: more BACs means better coverage of the
region involved (chromosome arm) and consequently smaller
chance to be inﬂuenced by a random variation of the mean sig-
nal ratio caused by ampliﬁcation bias; using pools of smaller
numbers of BACs on the glass means decreased array com-
plexity with increased probe complexity and greater robust-
ness; (iii) the total number of spots on the array is kept low in
order to minimize the hybridization area, which enables the
use of a relatively high amount of DNA per unit area.
We have used this strategy to produce mini-arrays of max-
imally 48 different spots, spotted in 5-fold, of which each spot
covers (a pool of evenly distributed ﬂawless ﬁve BAC clones)
a humanchromosome arm; 43 different chromosome arms and
control spots (Drosophila BAC, C0t-1 DNA). The perform-
ance of these mini-arrays was evaluated on cell lines with
known gains and losses, with special emphasis on reducing
assay time and amount of target DNA.
We have shown that gains and losses of relatively large
genomic regions such as full chromosomes and chromosomal
arms are reliably detected in <4 h. Our results indicate that
such achievement can be obtained with much lower amounts
of target DNA.
MATERIALS AND METHODS
Clone selection for production of mini-arrays
For clone selection, array-CGH results of thirty normal
genomic DNA samples using in house produced 3.5 k BAC
arrays (probes kindly provided by the Sanger Centre,
Cambridge, UK) were taken (7,8). The normalized mean
ratio of triplicate spots of each BAC clone was used to cal-
culatethenormalizedmeanratiooverthirtyhybridizationsand
its corresponding standard deviation. These values were used
to select ﬁve clones for each chromosome arm, with a mean
value close to 1 and a relatively low standard deviation (typ-
ically below 0.03). From this set ﬁve clones evenly distributed
over a given chromosome arm were selected and pooled, see
Supplementary Data (clone names and positions are according
to freeze November 2004 at Ensembl site: http://nov2004.
archive.ensembl.org/). Care was taken not to select clones
too close to centromeric or telomeric regions since these
are known to contain higher amounts of repetitive sequences
and might be involved in segmental duplications.
Generation of mini-arrays
BAC DNAs were isolated from bacterial clones, using the
Wizard SV 96 Plasmid DNA Puriﬁcation System (Promega,
Leiden, The Netherlands) in combination with the Biomek
2000 Laboratory Automation Workstation (Leiden
Genomic Technology Center facilities (LGTC), Leiden,
The Netherlands). This DNA puriﬁcation kit is designed to
isolate DNA from plasmids and results in small amounts of
DNA (100 ng DNA from 1 ml culture) when used for BAC
isolation. However, in our experience, this system was easier
to implement using robotics than usual protocols for BAC
DNA isolation. The resulting DNA had low levels of contam-
ination from the host Escherichia coli, and was suitable for
DNA ampliﬁcation and subsequent array production. Ampli-
ﬁcation of the DNA, spotting on the slides and hybridization
procedures were based on protocols optimized by the group of
Dr N.P. Carter (Wellcome Trust Sanger Institute, UK). This
set of BACs and protocols are described in detail [see ref
(7,8)]. For each chromosome arm 20 ml from the secondary
DOP PCR ampliﬁed product of each selected BAC clone was
pipetted together. These clone mixtures were precipitated with
sodium acetate and ethanol and dissolved again in spotting
buffer at 1 mg/ml concentration in 20 ml volume. Spotting was
done using an Omnigrid 100 Microarrayer (Genomic Solu-
tions, Ann Arbor, MI) at the Leiden Genome Technology
Center facilities (LGTC, Leiden, The Netherlands). A total
of 43 clone mixes was spotted, for each of chromosome
one arm; as control probes non-human DNA derived from
Droshophila melanogaster and amino labelled C0t-1 DNA
were spotted.
In addition, one spotting well containing material of four
BAC clones derived from the long arm of chromosome 4 and
one BAC clone derived from the long arm of chromosome X
was prepared; the mixture was spotted and used as a control to
show the sensitivity and the dynamic range of detection.
Each clone mixture was spotted ﬁve times on the array,
(average spot size: 150 mm; spot-to-spot distance: 300 mm)
resulting in a mini-array of 4.5 by 5 mm containing 240 spots
(0.225cm
2).
Test material
Performance of the mini-arrays for detecting abnormalities
was tested ona setof8celllines with conﬁrmed abnormalities,
diagnostically important in clinical cytogenetics. The
abnormalities were 47,XX,+13; 47,XX,+18; 47,XX,+21;
46,XX,i(18)(q10); 45,X0; 47,XXX; 47,XXY; 49,XXXXY.
In addition two solid tumour cell lines were investigated, a
Ewing Sarcoma (TC32) and a T cell lymphoma. For all
samples also 3.5 k array-CGH analysis was performed for
comparison.
DNA isolation, fluorescent labelling and hybridization
Test DNA of the cell lines was isolated using a High Pure PCR
Template Preparation Kit, (Roche diagnostics, Mannheim,
Germany).
Both test and reference DNA were labelled using the
BioPrime  DNA Labelling System (Invitrogen, Breda, The
Netherlands) with an adapted dNTP mix (7). A total of 100 ng
of each DNA were labelled overnight, either with Cy3 or Cy5
dCTP (Amersham, Roosendaal, The Netherlands) with an
additional 20 mM of sodium chloride in a total reaction
volume of 30 ml. The labelled test and reference DNA were
mixed together and precipitated with 37.5 mgC 0t-1 DNA
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hybridization buffer [50% formamide, 2· SSC, 10% dextran
sulphate, 0.1% Tween-20, 10 mM Tris–HCl (pH 7.4) and
25 mM EDTA (pH 8.0)] and 2 mlo fy e a s tt R N A( 1 0 0mg/ml,
Invitrogen, Breda, The Netherlands). Slides were hybridized
using 9 by 9 mm frame-seal chambers (BioRad, Veenendaal,
The Netherlands) without cover slip. Pre-hybridization was
not found necessary and omitted. Hybridization was per-
formed in an airtight sealed humidiﬁed chamber, originally
a microscope slide storage box with a moist paper on the
bottom, containing 50% formamide, 2· SSC, pH 7 and sealed
with formamide resistant tape. The hybridization was done
overnight in a 37C incubator on a slowly rocking table.
After hybridization, the frames were removed and slides
were washed in a solution of 50% formamide, 2· SSC,
pH 7, at 48C for 15 min, followed by a wash in 2· SSC
and 0.1% SDS, at 48C for 30 min. The slides were transferred
to a 0.1 M phosphate buffer, pH 8 with 0.1% Igepal (Sigma-
Aldrich Chemie B.V., Zwijndrecht, The Netherlands) at room
temperature and washed for 10 min. Then the slides were
dipped brieﬂy in MilliQ water and were spun dry.
For dilution experiments 3-fold dilutions of the labelled
target DNA were prepared and used with different hybridiza-
tion times (4, 8, 16 and 24 h). In these experiments, all other
conditions were kept the same as described above.
Data analysis
The arrays (3.5 k and mini-arrays) were scanned using a
GenePix 4100A scanner (Axon Instruments, Union City,
CA). Images were processed using GenePix Pro 4.1 software.
Pixel intensities for each feature were integrated and median
values were determined, and the local background was
calculated. For each spot the intensities were corrected
(pixel median values) by subtracting the local background
(pixel median values) for both wavelengths. The median
of the ratios of all spots was calculated and used to normal-
ize all data points. From each feature, the log2 value of the
average of the normalized ratios of the ﬁve spots was cal-
culated and used to display the data. For each feature
(5 spots) the mean value and its standard deviation were cal-
culated. Target values with a standard deviation greater than
±0.2 or signal to background ratios <2 were excluded. A con-
ventional threshold of ±0.25 (on a log2 scale) was used to
identify gains and losses.
RESULTS
Pools of normal male and female genomic DNA (Promega,
Leiden,The Netherlands)were usedtodo self-selfand gender-
mismatched hybridizations, followed by gender-mismatched
hybridization of genomic DNA of cell lines with known tri-
somies and monosomies. Spot-to-spot variation within the ﬁve
replicates was generally below six percent and all expected
trisomies and monosomies were picked up with no false pos-
itives or false negatives. For potential diagnostic purposes one
may consider to ﬁlter the data using the minimum/maximum
outlier reduction removing the highest and lowest ratio value
Figure1. TypicalexamplesofCGHresultsobtainedwithmini-arrays(forassayconditionsseeelsewhere).Thelog2valueoftheratioisplottedforthepandqarmof
each chromosome, starting with chromosome 1p and ending with chromosome Yq. For Figures A–C independent duplo experiments are plotted in the same graph,
one experiment is presented with open circles and the other experiment with closed circles. (A) 47,XX,+13 versus 46,XY; (B) 46,XX,i(18)(q10) versus 46,XY;
(C) 47,XX,+21 versus 46,XY; (D) average ratio and standard deviation for all chromosome arms was calculated and plotted for 12 independent assays;. The total
average standard deviation was 0.034.
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outlier reduction the spot-to-spot variation between the
remaining triplicates dropped in general below 4%. In
Figure 1, three representative examples of ratio plots of
trisomy DNA versus gender-mismatched normal reference
hybridizations are given.To show inter-experimental variation
and reproducibility, the ratio plots of the repeated experiment
is also given in the same ﬁgure (open and closed circles).
For twelve separate hybridizations, the normalized average
ratio and its standard deviation was calculated. To generate
this data set, normal samples and samples with gains and
losses were taken. Therefore to calculate the standard devi-
ation of each chromosome arm representing clone pools, indi-
vidual data points were omitted from samples with gains and/
or losses (trisomy/monosomy). For example in case of chro-
mosome 13 trisomy the ratio value of the chromosome 13q
feature was omitted and all other values were used to generate
the mean ratio and standard deviation of all other, non-altered
clones. The average ratio and variation of these data points per
clone is displayed in Figure 1D. The total average standard
deviation was 0.034. Signal to background ratios in all stand-
ard hybridizations were comparable. As an additional qual-
ity measure for hybridization speciﬁcity we calculated the
ratio of the human BAC signals compared to two different
Drosophila BAC clones and to amino-modiﬁed C0t-1 DNA.
In a standard hybridization ratio of the human BAC signal
over the Drosophila clones was on average 12.1 and 14.3 for
Cy5 and Cy3, respectively. The ratio of the human BAC
signals over the spotted human C0t-1 was on average 10.8
for Cy5 and 11.4 for Cy3, while the signal versus background
ratios were 14.3 and 18.6 for Cy5 and Cy3, respectively. The
intensity ratio of the non-human sequences is a measure of
hybridization stringency; the intensity ratio of the C0t-1 is a
measure of the efﬁcacy of repeat blocking and hybridization
stringency.
The number of selected BAC clones to generate a pool of
any given region of interest will determine the possible
inﬂuence/sensitivity of an individual clone to detect a rearran-
gementsmaller thanachromosomearmorinthecontrarytobe
inﬂuenced by the variation in mean signal ratio due to under-
orover-representation of genomic regions after ampliﬁcations.
For example by using only two clones as a pool, a single copy
gain or loss of the genomic region covered by only one of the
two clones would result in 50% increase or decrease the ratio
of the pooled spot, while using pools of ﬁve clones this inﬂu-
ence would be only 20%. The number of clones to be selected
might vary depending on the goal of the potential application
from 5 to 10. The results obtained with the mini-arrays under
the conditions described were very similar tothe onesobtained
by the larger 3.5 k array (Figure 2). All full chromosome arm
copy number changes were perfectly identiﬁed, while a small
interstitial deletion (<4 Mb) on 2q and a complex interstitial
deletion pattern on chromosome 13 involving several regions
were not reaching the log2 ±0.25 threshold value. By using
the 3· SD to set a threshold (0.109) for the 13q represent-
ing clone (0.098) (Figure 2A and C) the deletion was not
detected.
To further test the performance of the mini-array, one BAC
clone in a clone mix for the long arm of chromosome 4 was
replaced with a BAC clone, unique for chromosome X. One
would expect the ratio of this clone mix in a normal-to-normal
gender-mismatched hybridization to increase with one ﬁfth of
the ratio difference between the X chromosome clones and the
autosomal clones. Here using a threshold value based on 3·
SD (0.09), the ampliﬁcation (0.142) was readily detected.
Subsequently, for a trisomy X sample assayed against a
male reference sample, the ratio of the clone mix with one
chromosome X clone is expected to increase accordingly
(0.257). Figure 3A and B shows that the results obtained
for both experiments well match the theoretical expectation.
This proves that one BAC contributes to a ﬁfth of the ratio as it
is expected. The use of this information provides the possib-
ility to detect genomic imbalances involving only a part of any
       
 
     
 
 
 
Figure 2. Comparison of performance of the mini-array (A) and a 3.5 k BAC
array (B) for a similarly labelled sample of a blastic NK cell lymphoma (using
gendermatchedreferenceDNA).Allclonesareplottedasdescribedbefore.All
gains and losses observed in B were also seen in A, with two exceptions:
chromosome 2q shows only 5 consecutive clones deleted which were not
detected by the mini-array, and chromosome 13 represents a complex deletion
patternwhichisfurtherelucidatedin(C).ThechoiceofBACclonesusedinthe
mini-array,depictedasclosedsquares,causedthisdeletionpatterntobemissed.
These two exceptions illustrate the limit of the technique.
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3· SD of any given clone.
Finally, the amount of labelled target DNA was diluted and
the hybridization time was reduced. Although larger variat-
ions in normal region became apparent, the abnormalities
were still detectable when DNA equivalents of 30 ng of target
DNA was used at a hybridization time of only 4 h (Figure 4A),
using only 10 ng of target DNA detection identiﬁcation of
alterations was not possible (Figure 4B). However, 10 ng of
target DNA was found adequate when the hybridization period
was extended to 18 h.
DISCUSSION AND CONCLUSIONS
In the past decade genomic arrays have been successfully used
to detect genomic ampliﬁcations and deletions in virtually all
types of human tumours. For a few, the abnormalities found
are characteristic and allow identiﬁcation of the tumour type,
or they are used prognostically or provide extra rational for
selection of proper therapy. The majority of abnormalities
found however, is strongly case dependent and occurs all
over the genome, albeit that some regions are more frequently
involved than others. Array-CGH has been an extremely valu-
able discovery tool, which in many cases has elucidated amp-
liﬁcations and deletions that represent the critical steps in
tumourigenesis of many tumours. A signiﬁcant improvement
in detecting smaller ampliﬁcations and deletions was made
with the introduction of spotted high-density BAC arrays
(35 k), or high-density oligonucleotide arrays to detect single
nucleotide polymorphisms (SNPs). The higher resolution data
that is produced with these devices is ongoing, and the number
of clinically relevant gene ampliﬁcations and deletions is
increasing.
When the aim is diagnosis rather than discovery, the situ-
ationchanges.Althoughgenomic arrays obviouslycanbeused
diagnostically, there are many suitable alternatives, the choice
of which depends on a number of variables. First, the multi-
plicity, that is the number of gene regions that have to be
investigated. When small, interphase cytogenetics is a good
alternative, for instance the use of a two colour ﬂuorescence
in situ hybridization (FISH) test to demonstrate Her2/Neu
ampliﬁcation for selection of Herceptin  treatment for breast
cancer. When the number of targets is higher, for instance up
to 100, other technologies are of interest. Examples are bead-
based platforms or multiplex ligation-dependent probe amp-
liﬁcation (MLPA) (10). As this test format requires a 5th to
10th of labelled DNA to hybridize, consequently the use of a
mini-array system could reduce the labelling related costs to
the same extent. In addition, multiple mini-arrays could be
spotted on one array-slide (three in our system, but four or
more could be adapted) resulting in a proportional reduction of
slide related costs per assay. These considerations would
Figure 3. This figure shows the sensitivity and accuracy of the mini-array.
(A) One BAC clone (out of five) in a clone mix for an autosomal chromosome
armwasreplacedwithaBACclone,uniqueforchromosomeXq26andtestedin
anormal-to-normalgender-mismatchedhybridization.Thisclonemixisdepic-
ted as closed triangles. Note the corresponding increase with one fifth of the
ratio difference between the X chromosome clones and the autosomal clones.
(B) A trisomy X sample was assayed against a male reference sample; note the
expected increase in ratio of the X region.
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Figure 4. The effect of a decreased hybridizationtime and the amountof input
materialisshownhere.(A)ReducingtheinputDNAandlabellingvolumewith
athirdto30ngand10ml,respectively,andlimitingtimeto4hofhybridization
still gives good results, while using only again a third of the labelling product
(10 ng input) in 4 h of hybridization (B), gains and losses are not picked up
anymore with the current thresholds.
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in a kind of pre-testing of samples (information about sample
quality) before one would use an array with higher resolution
and higher related costs.
Here we show a strategy to match the performance of
(home) spotted BACs to the goal for which they are used.
Earlier, attempts have been made to pool chromosomal paint-
ing probes, and produce mini-array to detect aneusomies, but
withlimitedsuccess(11).Thecomplexity ofpainting probesis
much higher (the complexity of a spot element is a full chro-
mosome) than the BAC clones (one spot element containing
ﬁve clones distributed over a given chromosome arm) used
here. Also, that approach lacked the possibility of selecting the
BAC clones with the best performance, and in the desired
number.
The mini-arrays show excellent performance in detecting
aneuploidy of a given chromosome, a feature that for instance
ﬂow cytometry does not offer. More importantly, informative
results can be obtained using low amounts of target DNA, and
easily within one day, DNA isolation and labelling included.
Low amounts of target DNA are important when only limited
material of small tumours or their metastases is available.
When one accepts a limited resolution of one chromosomal
arm, mini-arrays may also be applied for genomic proﬁling of
disseminated tumour cells that are isolated from bone marrow
by micromanipulation of by laser microdissection; a situation
where the amount of DNA is very restricted. For all data
shown in Figures 1–4 we used exclusively random primed
labelled DNA and did not apply techniques such as linker-
adapter PCR or j-29 phage ampliﬁcation that are successfully
used to amplify DNA isolated from single cells (4). In com-
bination with such ampliﬁcation techniques, a highly interest-
ing application of this mini-array strategy could be detection
of chromosomal aneusomies in the context of preimplantation
genetic diagnosis (PGD). PGD of single blastomeres to detect
aneusomies has been shown to increase the success rate in
pregnancy after IVF embryo transfer, since implantation of
embryos with aberrant chromosome numbers can be avoided
to a large extent (12). However, tests so far available do not
provide information about all chromosomes (for instance
interphase FISH (13) or take too long to be completed in
one day (e.g. CGH) (14). Single cell CGH for PGD described
byWilton et al., is a very labour-intensive procedure, taking as
much as 5 days to obtain a result, which is incompatible with
the current laboratory framework of PGD (14, 15). The fact
that by using mini-array-CGH information about all chromo-
somes can be provided well within one day, as we show here,
could have, if applicable for single cells, a signiﬁcant impact
on the success rate of preimplantation genetic diagnosis.
In the framework of these considerations we performed a
pilot experiment to investigate the feasibility of such an
approach. Without further optimization and ﬁne-tuning of
the ampliﬁcation procedure we performed a pilot experiment
using 200 pg (equivalent of 30 cells) of GenomiPhi ampli-
ﬁed DNA. Very encouraging results similar to those shown in
Figure 4A were obtained for a hybridization time of 18 h,
implying that the whole test could be performed within
24 h. Fine-tuning and evaluation of ampliﬁcation protocols
that have been designed for single cell analysis (3,4), is indic-
ated to achieve single cell level performance.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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